| Website | fletcherspaght.co... |
| Phone | 617-247-6700 |
| info@fletcherspag... | |
| Employees | |
| Founded | 2001 |
| Description | Venture Capital Firm |
Fletcher Spaght Ventures, L.P. (FSV) is a venture capital firm investing in emerging growth healthcare and high technology companies. Differentiating it from other venture capital firms, FSV is able to leverage the strengths, experience and extensive VC and industry network of its partner consulting business, Fletcher Spaght, Inc. in identifying investment opportunities and providing post-investment support.
| Company | Date | Round | Size | Participants |
| SurgiQuest | 12/12 | Series D | $7.5M | 5 |
| Juventas Therapeutics | 7/12 | Series B | $22.2M | 7 |
| PhaseBio Pharmaceuticals | 6/12 | Series B | $23M | 5 |
| Cayenne Medical | 2/12 | Venture Round | $10M | 4 |
| Metabolon | 8/11 | Series D | $13.1M | 6 |
| SironRX Therapeutics | 8/11 | Series A | $3.4M | 6 |
| SurgiQuest | 7/11 | Series C | $19M | 5 |
| CardioFocus | 2/11 | Series C | $30.6M | 9 |
| HTG Molecular Diagnostics | 2/11 | Series D | $15.7M | 4 |
| High Throughput Genomics | 2/11 | Series D | $15.7M | 5 |
| PhaseBio Pharmaceuticals | 1/10 | Series B | $25M | 5 |
| Metabolon | 12/09 | Series C | $6M | 7 |
| Interactive Supercomputing | 10/07 | Series B | $11M | 5 |
| PhaseBio Pharmaceuticals | 10/07 | Series B | $6.6M | 3 |